Journal
FRONTIERS IN IMMUNOLOGY
Volume 11, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2020.613170
Keywords
cytokines; interleukin-1; inflammasome; innate immunity; inflammation; adaptive immunity
Categories
Funding
- British Heart Foundation [FS/09/005/26845, FS/13/3/30038, FS/18/19/33371, RG/16/8/32388, RE/13/6/30180]
- Cambridge NIHR Biomedical Research Centre
Ask authors/readers for more resources
Cytokines activate or inhibit immune cell behavior and are thus integral to all immune responses. IL-1 alpha and IL-1 beta are powerful apical cytokines that instigate multiple downstream processes to affect both innate and adaptive immunity. Multiple studies show that IL-1 beta is typically activated in macrophages after inflammasome sensing of infection or danger, leading to caspase-1 processing of IL-1 beta and its release. However, many alternative mechanisms activate IL-1 alpha and IL-1 beta in atypical cell types, and IL-1 function is also important for homeostatic processes that maintain a physiological state. This review focuses on the less studied, yet arguably more interesting biology of IL-1. We detail the production by, and effects of IL-1 on specific innate and adaptive immune cells, report how IL-1 is required for barrier function at multiple sites, and discuss how perturbation of IL-1 pathways can drive disease. Thus, although IL-1 is primarily studied for driving inflammation after release from macrophages, it is clear that it has a multifaceted role that extends far beyond this, with various unconventional effects of IL-1 vital for health. However, much is still unknown, and a detailed understanding of cell-type and context-dependent actions of IL-1 is required to truly understand this enigmatic cytokine, and safely deploy therapeutics for the betterment of human health.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available